News
-
Dr. Jerome Rotter Recognized Among the World’s Leading Geneticists by Research.com
Dr. Jerome I. Rotter, Executive Data Science Officer at The Lundquist Institute, has been recognized by Research.com as one of the world’s leading geneticists, earning designation as a 2026…
Advanced Therapeutics and Biomedical TechnologiesResearchJuly 9, 2026 -
Exercise Medicine: Building the Future at The Lundquist Institute
Editor’s Note: This is Part 1 of our three-part series exploring how The Lundquist Institute is helping shape the emerging field of Exercise Medicine. Read Part 2: Training the…
Systems Medicine and Precision PreventionInnovation, ResearchJuly 8, 2026 -
Could the Nervous System Hold the Key to Better Asthma Treatments?
Asthma affects millions of people across the United States, making everyday activities like exercising, laughing, or even taking a deep breath difficult. Although treatments can help…
Infectious Diseases and ImmunologyResearchJuly 8, 2026 -
The Lundquist Institute Showcases Global Health Research During Gates Foundation Campus Visit
Representatives from the Gates Foundation recently visited The Lundquist Institute to learn more about research and innovation efforts underway across the organization, including projects currently supported…
Leadership, ResearchJuly 7, 2026 -
The Uppuluri Laboratory Receives NIH R21 Funding to Advance Research on Catheter-Associated Fungal Biofilms
The National Institutes of Health (NIH) has awarded an R21 grant titled “Regulation of Candida albicans Central Venous Catheter Biofilms by Transcription Factor Networks” to Priya Uppuluri, PhD, investigator…
Infectious Diseases and ImmunologyResearchJuly 1, 2026 -
Advancements in Lung Sensing Research Lead to New Priorities for Experts Across Disciplines
Nicholas Jendzjowsky, PhD, an investigator at The Lundquist Institute for Biomedical Innovation, along with collaborators across the country, spearheaded the National Heart, Lung, and Blood Institute…
Infectious Diseases and ImmunologyResearchJune 24, 2026 -
Fighting Drug-Resistant Fungi: NIH Funds Innovative Antifungal Research at The Lundquist Institute
The Lundquist Institute for Biomedical Innovation received new funding from the National Institutes of Health (NIH) to advance cutting-edge research targeting life-threatening fungal infections. Led by…
Infectious Diseases and ImmunologyResearchJune 15, 2026 -
Research Suggests Nicotine Exposure May Impact Heart Health Beyond One Generation
Since 2012, Virender K. Rehan, MD, an investigator at The Lundquist Institute for Biomedical Innovation, has studied how perinatal nicotine exposure affects health across generations. Building on earlier…
ResearchJune 10, 2026 -
Dr. Al Alam Awarded NIH Grant to Enhance Research Infrastructure
The Lundquist Institute for Biomedical Innovation is pleased to announce that Denise Al Alam, PhD has been awarded a prestigious S10 Instrumentation Grant from the National Institutes of Health (NIH) Office…
Advanced Therapeutics and Biomedical TechnologiesResearchJune 4, 2026 -
Opening New Pathways for Discovery: Celebrating the Launch of SPRINT CIRM SRL Core at TLI
On May 26, 2026, The Lundquist Institute proudly celebrated the grand opening and official launch of the CIRM-funded Shared Resources Laboratory, SPRINT Core (Stem cell-based Partnership Resource for INvestigating Human Diseases and Training). The ribbon-cutting event marked the beginning…
Leadership, ResearchJune 3, 2026